Pulmonary arterial hypertension in a child with stage‐IV neuroblastoma after autologous hematopoietic stem cell transplantation and review of the literature

PH is a rare condition with high mortality rate after pediatric HSCT. As clinical presentation is non‐specific and may mimic other conditions, a high degree of suspicion is required for diagnosis. Here, we present a patient with stage‐IV neuroblastoma who developed PAH after autologous HSCT. After e...

Full description

Saved in:
Bibliographic Details
Published inPediatric transplantation Vol. 19; no. 7; pp. E185 - E188
Main Authors Özyörük, Derya, Kibar, Ayşe Esin, Sürücü, Murat, Azak, Emine, Emir, Suna, Çetin, İbrahim İlker, Tunç, Bahattin, Özbek, Namık Yaşar
Format Journal Article
LanguageEnglish
Published Denmark 01.11.2015
Subjects
Child, Preschool
children
hematopoietic stem cell transplantation
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - etiology
Male
Neoplasm Staging
Neuroblastoma - pathology
Neuroblastoma - therapy
pulmonary hypertension
Transplantation, Autologous
hematopoietic stem cell transplantation
children
pulmonary hypertension
Online AccessGet full text

Cover

More Information
Summary:PH is a rare condition with high mortality rate after pediatric HSCT. As clinical presentation is non‐specific and may mimic other conditions, a high degree of suspicion is required for diagnosis. Here, we present a patient with stage‐IV neuroblastoma who developed PAH after autologous HSCT. After exclusion of other causes of PH, we regarded that this condition was secondary to HSCT.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ISSN:1397-3142
1399-3046
DOI:10.1111/petr.12576